What is the most recent earnings date for TFFP stock?
TFF Pharmaceuticals Inc (TFFP) last reported earnings on 11/20/2024.
TFF Pharmaceuticals Inc (TFFP) Earnings History & Surprises
NASDAQ:TFFP • US87241J2033
Current stock price
0.065 USD
-0.1 (-60.05%)
At close:
0.135 USD
+0.07 (+107.69%)
After Hours:
TFFP Earnings overview
Past quarterly earnings results for TFF Pharmaceuticals Inc (TFFP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$0.74
- Revenue Estimate
- 204K
Last Reported
Most Recent- Release Date
- Nov 20, 2024
- Period
- Q3 / 2024
- EPS Reported
- -$0.81
- EPS Surprise
- 1.96%
- Revenue Surprise
- -5.20%
Beat Rate
Last 8 Quarters 81%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -0.81 | -0.83 | 1.96% | 64.00% | 193.39K | 204K | -5.20% | -17.71% |
| Q2 2024 | -1.22 | -1.73 | 29.64% | 65.14% | 650K | 153K | 324.84% | 95.20% |
| Q1 2024 | -2.40 | -2.31 | -4.11% | 49.47% | 203K | 76.5K | 165.36% | 298.04% |
| Q4 2023 | -2.01 | -2.16 | 7.05% | 19.60% | 114.33K | 102K | 12.09% | -63.47% |
| Q3 2023 | -2.25 | -2.93 | 23.27% | -675.86% | 235K | 51K | 360.78% | 161.11% |
| Q2 2023 | -3.50 | -4.85 | 27.76% | -929.41% | 333K | 68.003K | 389.68% | 1,010.00% |
| Q1 2023 | -4.75 | -5.87 | 19.01% | -1,339.39% | 51K | 255K | -80.00% | -27.14% |
| Q4 2022 | -2.50 | -6.12 | 59.15% | -525.00% | 313K | 20.4K | 1,434.31% | 3,030.00% |
| Q3 2022 | -0.29 | -0.34 | 14.71% | 14.71% | 90K | - | 80.00% | |
| Q2 2022 | -0.34 | -0.33 | -4.17% | -88.89% | 30K | - | - | |
| Q1 2022 | -0.33 | -0.39 | 14.86% | - | 70K | 51K | 37.25% | 250.00% |
| Q4 2021 | -0.40 | -0.28 | -42.60% | -53.85% | 10K | 957.27K | -98.96% | - |
| Q3 2021 | -0.34 | -0.19 | -75.44% | -41.67% | 50K | 1.734M | -97.12% | - |
| Q2 2021 | -0.18 | -0.31 | 42.46% | 10.00% | - | - | ||
| Q1 2021 | -0.33 | -0.24 | -34.80% | -65.00% | 20K | - | - | |
| Q4 2020 | -0.26 | -0.24 | -9.25% | - | 255K | -100.00% | - | |
| Q3 2020 | -0.24 | -0.19 | -23.84% | - | 510K | -100.00% | - | |
| Q2 2020 | -0.20 | -0.22 | 8.80% | - | - | - | ||
| Q1 2020 | -0.20 | -0.24 | 18.30% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
8.63%
Max EPS beat (4)
29.64%
Min EPS beat (4)
-4.11%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
124.27%
Max Revenue beat (4)
324.84%
Min Revenue beat (4)
-5.20%
Analysis
In the last 4 quarters, TFFP has beaten EPS estimates in 3 out of 4 releases
TFFP has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, TFFP has beaten the EPS estimates by 8.6% on average.
In the last 4 quarters, TFFP has beaten the revenue estimates by 124.3% on average.
Related analysis
TFF Pharmaceuticals Inc / TFFP Earnings FAQ
Can you provide information on whether TFF Pharmaceuticals Inc beat earnings estimates in the last quarter?
TFF Pharmaceuticals Inc (TFFP) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does TFF Pharmaceuticals Inc (TFFP) beat earnings estimates?
In the last 4 quarters, TFF Pharmaceuticals Inc (TFFP) has beaten EPS estimates in 3 out of 4 releases.